Insa Schiffmann studied Medicine at the University of Freiburg and Sevilla and started her residency in 2017 at the MS day hospital and outpatient clinic of the University Medical Center Hamburg Eppendorf (UKE). In her thesis she examined the effects of epigenetic drugs on histone modifications in Non-small cell lung cancer. She is a member of the research team of Prof. Heesen focusing on evidence-based medicine and patient information in MS.
Link to Pubmed